Psilocybin molecule:

Image from PubChem

Psilocybin Clinical Trials

Psilocybin vs. escitalopram for major depressive disorder: comparative mechanisms

To see complete record on, please visit this link

Id: 2017-000219-18

Organisation Name: Imperial College London

Start Date: 2018-04-09

Completion Date: Ongoing

Brief Summary: How effective is a single dose of psilocybin for major depressive disorder against an an active gold-standard medical treatment (6-weeks of escitalopram)?

Country: United Kingdom

Total execution time in seconds: 0.090524196624756